A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer

• Main Authors: Ni, Q, Zhang, F, Liu, Y, Wang, Z, Yu, G, Liang, B, Niu, G, Su, T, Zhu, G, Lu, G, Zhang, L, Chen, X
• Other Authors: DIAGNOSTIC RADIOLOGY
• Format: Article
• Published: American Association for the Advancement of Science (AAAS) 2022
• Subjects: Adjuvants, Immunologic; Animals; Antigen Presentation; Antigens, Neoplasm; Antineoplastic Agents, Immunological; Cancer Vaccines; Colorectal Neoplasms; Combined Modality Therapy; Dendritic Cells; Disease Models, Animal; Humans; Immunogenicity, Vaccine; Immunotherapy; Mice; Nanoparticles; Nanotechnology; Programmed Cell Death 1 Receptor; T-Lymphocytes; Theranostic Nanomedicine; Xenograft Model Antitumor Assays
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/234937
• Institution: National University of Singapore

10.1126/sciadv.aaw6071